Application of ultrasound-guided nerve block in breast cancer operation

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000033275

Enrollment

Unknown

Registered

2020-05-26

Start date

2020-06-01

Completion date

Unknown

Last updated

2022-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Nerve block group:ultrasound-guided Pectoral nerve block and anterior serratus plane block

control group:general anesthesia

Eligibility

Sex/Gender

Female

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Female; 2. ASA I-II, 18-65 years old, BMI <=30 kg / m2; 3. Patients without obvious abnormality of coagulation function; 4. Patients without serious systemic diseases such as heart, lung, liver and kidney before operation; 5. Subjects with no history of local anesthetic allergy, rib fracture and chest wall operation.

Exclusion criteria

Exclusion criteria: 1. Patients who can not cooperate and are allergic to local anesthetics (LA) or opioids; 2. Patients with a history of regular daily intake of opioids; 3. Patients with severe infection of injection site or whole body; 4. Patients with anatomical difficulties leading to poor ultrasound display of muscle and fascia structures required for nerve block administration.

Design outcomes

Primary

Measure	Time frame
IL-6;CRP;WBC;	—

Countries

China

Contacts

Public ContactChen Jing

The First Affiliated Hospital of Guangxi Medical University

352880721@qq.com+86 13607815280

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026